Evidence map›Paper›PMID 32677466›Full record

ArticleEpigenomics2020

Epigenomic programming in early fetal brain development.

Luolan Li, Cecile L Maire, Misha Bilenky, Annaïck Carles, Alireza Heravi-Moussavi, Chibo Hong, Angela Tam, Baljit Kamoh, Stephanie Cho, Dorothy Cheung and 13 more

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Epigenomics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Implications of Extended Inhibitory Neuron Development.International journal of molecular sciences · 2021
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 6 institutions in 2 countries.

Luolan LiDepartment of Microbiology & Immunology, Michael Smith Laboratories, University of British Columbia, Vancouver, BC, V6T 1Z4, Canada.
Cecile L MaireDepartment of Medical Oncology, Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
Misha BilenkyCanada's Michael Smith Genome Science Center, BC Cancer, Vancouver, BC, V5Z 4S6, Canada.
Annaïck CarlesDepartment of Microbiology & Immunology, Michael Smith Laboratories, University of British Columbia, Vancouver, BC, V6T 1Z4, Canada.
Alireza Heravi-MoussaviCanada's Michael Smith Genome Science Center, BC Cancer, Vancouver, BC, V5Z 4S6, Canada.
Chibo HongDepartment of Neurological Surgery, University of California San Francisco, San Francisco, CA 94158, USA.
Angela TamCanada's Michael Smith Genome Science Center, BC Cancer, Vancouver, BC, V5Z 4S6, Canada.
Baljit KamohCanada's Michael Smith Genome Science Center, BC Cancer, Vancouver, BC, V5Z 4S6, Canada.
Stephanie ChoCanada's Michael Smith Genome Science Center, BC Cancer, Vancouver, BC, V5Z 4S6, Canada.
Dorothy CheungCanada's Michael Smith Genome Science Center, BC Cancer, Vancouver, BC, V5Z 4S6, Canada.
Irene LiCanada's Michael Smith Genome Science Center, BC Cancer, Vancouver, BC, V5Z 4S6, Canada.
Tina WongCanada's Michael Smith Genome Science Center, BC Cancer, Vancouver, BC, V5Z 4S6, Canada.
Raman P NagarajanDepartment of Neurological Surgery, University of California San Francisco, San Francisco, CA 94158, USA.
Andrew J MungallCanada's Michael Smith Genome Science Center, BC Cancer, Vancouver, BC, V5Z 4S6, Canada.
Richard MooreCanada's Michael Smith Genome Science Center, BC Cancer, Vancouver, BC, V5Z 4S6, Canada.
Ting WangDepartment of Genetics, Washington University, St Louis, MO 63108, USA.
Claudia L KleinmanDepartment of Human Genetics, McGill University, Montreal, QC, H3T 1E2, Canada.
Nada JabadoDepartment of Human Genetics, McGill University, Montreal, QC, H3T 1E2, Canada.
Steven Jm JonesCanada's Michael Smith Genome Science Center, BC Cancer, Vancouver, BC, V5Z 4S6, Canada.
Marco A MarraCanada's Michael Smith Genome Science Center, BC Cancer, Vancouver, BC, V5Z 4S6, Canada.
Keith L LigonDepartment of Medical Oncology, Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
Joseph F CostelloDepartment of Neurological Surgery, University of California San Francisco, San Francisco, CA 94158, USA.
Martin HirstDepartment of Microbiology & Immunology, Michael Smith Laboratories, University of British Columbia, Vancouver, BC, V6T 1Z4, Canada.ORCID 0000-0001-9136-9054
Canada's Michael Smith Genome Sciences Centre · CAUniversity of British Columbia · CAUniversity of California, San Francisco · USDana-Farber Cancer Institute · USMcGill University · CAWashington University in St. Louis · US

Funding

Integrated Epigenetic Maps of Human Embryonic and Adult CellsU01ES017154 · NIEHS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI COSTELLO, JOSEPH F, MARRA, MARCO ANTONIO · 2008 to 2012
$11.6M
MYB family alterations in pediatric gliomasR01CA215489 · NCI · DANA-FARBER CANCER INST · PI BEROUKHIM, RAMEEN, LIGON, KEITH LLOYD · 2017 to 2021
$2.8M
CIHR CIHR-262119NCI NIH HHS R01 CA215489NIEHS NIH HHS U01 ES017154
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Epigenesis, GeneticGene Expression Regulation, DevelopmentalBrainEpigenomeFemaleFetusHumansNeural Stem CellsPregnancyTranscriptomeTwinsbraincortexDNA methylationenhancerepigeneticsfetalganglionic eminencegestational weekneural progenitor cellstranscriptional network

Identifiers

PMID32677466
PMCPMC7857341
OpenAlexW3043186257

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.